Filana Therapeutics Inc (FLNA)

$1.73 +0.01 (0.58%)
Market Cap 83.57M
Revenue (ttm) 0.00
Net Income (ttm) -90.97M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 302,700
Avg Vol 650,546
Day's Range N/A - N/A
Shares Out 48.31M
Stochastic %K 39%
Beta -0.67
Analysts Strong Sell
Price Target $8.00

Company Profile

Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer's disease; and investigational diagnostic product candidate is SavaDx, an early-stage program focused on detecting the presence of Alzheimer's disease from a small sample of blood. The company was formerly known as Cassava Sciences, Inc. and changed its na...

Industry: Biotechnology
Sector: Healthcare
Phone: 512 501 2444
Address:
6801 N. Capital of Texas Highway, Building 1, Austin, United States
gogingergo
gogingergo Dec. 27 at 5:24 PM
$FLNA 🚀 AD Sava is winning
0 · Reply
jmashen
jmashen Dec. 22 at 6:30 PM
$FLNA I firmly believe some people are born a..holes. Read stocktwits guidelines. Blocked. Reported
1 · Reply
semifreeguy
semifreeguy Dec. 22 at 6:29 PM
$FLNA Gotta be very few shares left for the crooks to steal at this point
0 · Reply
Duboc1998
Duboc1998 Dec. 22 at 6:14 PM
$FLNA I bought at $30 & change and $32 & change so what does that add up I only know Simple arithmetic 1+ 1=5 Lol
0 · Reply
Bob_C
Bob_C Dec. 22 at 6:13 PM
$FLNA I said this before and I will say this again... The Drug Trials and those enrolled have ALREADY told everyone that this drug WORKS! Who continues taking a drug that doesn't work - Especially twice per day for YEARS! Folks, there are people in the trials who enrolled in the P2B blinded study in September 9, 2019 ALL BUT 1 appear to be enrolled in the P2B OL and now the CMS studies. HOW am I 100% sure the drug works? The Prior Results AND the fact people are staying in trials. In the P2b blinded study ONLY 1 person withdrew... NOW, we have had multiple results published since the 2b Blinded study and in EVERY ONE of the published results OVER 50% had positive Cog results and OVER 80% received benefits. Today is a buying opportunity! Compare it to the SHITTY Amlyoid Mafia Drugs that actually have killed people (the most recent joke of a drug has allegedly killed up to 13).
3 · Reply
jewell69
jewell69 Dec. 22 at 6:10 PM
@StuBeef Ok, Mr. Beef. Based on what YOU say, I am canceling my buy order for shares at 31.64 $FLNA
2 · Reply
NYNJlawyer
NYNJlawyer Dec. 22 at 6:07 PM
$FLNA took 1/2 hour to rise a dollar but only 3 minutes to lose it
2 · Reply
NYNJlawyer
NYNJlawyer Dec. 22 at 6:05 PM
$FLNA down $1 in 3 minutes, as always
1 · Reply
vu_jade
vu_jade Dec. 22 at 6:04 PM
$FLNA Cassava my nuts
0 · Reply
Duboc1998
Duboc1998 Dec. 22 at 6:03 PM
$FLNA sammy2626 What did you do with your son that you adopted did he accept the $100 Zelle LOL
0 · Reply
Latest News on FLNA
Cassava Sciences says US DOJ has closed investigation into company

Feb 19, 2026, 8:52 AM EST - 6 weeks ago

Cassava Sciences says US DOJ has closed investigation into company

HALPER SADEH LLC ENCOURAGES CASSAVA SCIENCES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Dec 24, 2025, 11:51 AM EST - 3 months ago

HALPER SADEH LLC ENCOURAGES CASSAVA SCIENCES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

FDA Puts Cassava's Simufilam Epilepsy Trial On Full Clinical Hold

Dec 19, 2025, 11:31 AM EST - 3 months ago

FDA Puts Cassava's Simufilam Epilepsy Trial On Full Clinical Hold

Halper Sadeh LLC Encourages Cassava Sciences, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Oct 22, 2025, 4:05 PM EDT - 5 months ago

Halper Sadeh LLC Encourages Cassava Sciences, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Cassava Sciences Appoints Dawn C. Bir to the Board of Directors

Oct 22, 2025, 8:00 AM EDT - 5 months ago

Cassava Sciences Appoints Dawn C. Bir to the Board of Directors

Cassava Reports Q2 2025 Financials Results and Provides Business Update

Aug 14, 2025, 7:30 AM EDT - 8 months ago

Cassava Reports Q2 2025 Financials Results and Provides Business Update

Cassava Sciences Appoints Dr. Joseph Hulihan as Chief Medical Officer

Aug 7, 2025, 7:30 AM EDT - 8 months ago

Cassava Sciences Appoints Dr. Joseph Hulihan as Chief Medical Officer

Cassava Sciences Reports Positive Preclinical Study Evaluating Simufilam for TSC-Related Epilepsy

Aug 4, 2025, 7:30 AM EDT - 8 months ago

Cassava Sciences Reports Positive Preclinical Study Evaluating Simufilam for TSC-Related Epilepsy

Cassava Presents Promising Preclinical Simufilam Data at TSC Alliance Meeting

Jun 30, 2025, 7:00 AM EDT - 9 months ago

Cassava Presents Promising Preclinical Simufilam Data at TSC Alliance Meeting

Cassava Appoints Angélique Bordey, PhD, to Enhance Preclinical Program in TSC

May 1, 2025, 7:30 AM EDT - 1 year ago

Cassava Appoints Angélique Bordey, PhD, to Enhance Preclinical Program in TSC

Cassava Announces Retirement of Chief Medical Officer, Dr. Jim Kupiec, and Appointment of Dr. Jack Moore as Senior Vice President, Clinical Development

Apr 21, 2025, 4:30 PM EDT - 1 year ago

Cassava Announces Retirement of Chief Medical Officer, Dr. Jim Kupiec, and Appointment of Dr. Jack Moore as Senior Vice President, Clinical Development

Cassava Sciences must face malicious prosecution lawsuit over Alzheimer's drug

Mar 26, 2025, 3:49 PM EDT - 1 year ago

Cassava Sciences must face malicious prosecution lawsuit over Alzheimer's drug

Cassava Sciences Discontinues Developing Simufilam For Alzheimer's After Another Phase 3 Trial Flop

Mar 25, 2025, 10:42 AM EDT - 1 year ago

Cassava Sciences Discontinues Developing Simufilam For Alzheimer's After Another Phase 3 Trial Flop

Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data

Mar 25, 2025, 8:05 AM EDT - 1 year ago

Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data

Cassava Sciences Reports 2024 Financial Results and Provides Business Update

Mar 3, 2025, 7:30 AM EST - 1 year ago

Cassava Sciences Reports 2024 Financial Results and Provides Business Update

Lead Plaintiff Deadline on February 10, 2025 for SAVA Investors - Kessler Topaz Meltzer & Check, LLP Encourages Investors with Losses to Contact the Firm

Feb 9, 2025, 10:45 AM EST - 1 year ago

Lead Plaintiff Deadline on February 10, 2025 for SAVA Investors - Kessler Topaz Meltzer & Check, LLP Encourages Investors with Losses to Contact the Firm

SAVA Deadline: Rosen Law Firm Urges Cassava Sciences, Inc. (NASDAQ: SAVA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Feb 7, 2025, 12:08 PM EST - 1 year ago

SAVA Deadline: Rosen Law Firm Urges Cassava Sciences, Inc. (NASDAQ: SAVA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Shareholders of Cassava Sciences, Inc. Should Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVA

Feb 3, 2025, 5:45 AM EST - 1 year ago

Shareholders of Cassava Sciences, Inc. Should Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVA

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava

Jan 23, 2025, 2:47 PM EST - 1 year ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava

Cassava Sciences Provides a Business Update

Jan 7, 2025, 4:30 PM EST - 1 year ago

Cassava Sciences Provides a Business Update

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 10, 2025 in Cassava Sciences, Inc. Lawsuit - SAVA

Dec 23, 2024, 5:45 AM EST - 1 year ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 10, 2025 in Cassava Sciences, Inc. Lawsuit - SAVA

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava

Dec 18, 2024, 10:53 AM EST - 1 year ago

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava

Rosen Law Firm Urges Cassava Sciences, Inc. (NASDAQ: SAVA) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Dec 13, 2024, 1:16 PM EST - 1 year ago

Rosen Law Firm Urges Cassava Sciences, Inc. (NASDAQ: SAVA) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights

gogingergo
gogingergo Dec. 27 at 5:24 PM
$FLNA 🚀 AD Sava is winning
0 · Reply
jmashen
jmashen Dec. 22 at 6:30 PM
$FLNA I firmly believe some people are born a..holes. Read stocktwits guidelines. Blocked. Reported
1 · Reply
semifreeguy
semifreeguy Dec. 22 at 6:29 PM
$FLNA Gotta be very few shares left for the crooks to steal at this point
0 · Reply
Duboc1998
Duboc1998 Dec. 22 at 6:14 PM
$FLNA I bought at $30 & change and $32 & change so what does that add up I only know Simple arithmetic 1+ 1=5 Lol
0 · Reply
Bob_C
Bob_C Dec. 22 at 6:13 PM
$FLNA I said this before and I will say this again... The Drug Trials and those enrolled have ALREADY told everyone that this drug WORKS! Who continues taking a drug that doesn't work - Especially twice per day for YEARS! Folks, there are people in the trials who enrolled in the P2B blinded study in September 9, 2019 ALL BUT 1 appear to be enrolled in the P2B OL and now the CMS studies. HOW am I 100% sure the drug works? The Prior Results AND the fact people are staying in trials. In the P2b blinded study ONLY 1 person withdrew... NOW, we have had multiple results published since the 2b Blinded study and in EVERY ONE of the published results OVER 50% had positive Cog results and OVER 80% received benefits. Today is a buying opportunity! Compare it to the SHITTY Amlyoid Mafia Drugs that actually have killed people (the most recent joke of a drug has allegedly killed up to 13).
3 · Reply
jewell69
jewell69 Dec. 22 at 6:10 PM
@StuBeef Ok, Mr. Beef. Based on what YOU say, I am canceling my buy order for shares at 31.64 $FLNA
2 · Reply
NYNJlawyer
NYNJlawyer Dec. 22 at 6:07 PM
$FLNA took 1/2 hour to rise a dollar but only 3 minutes to lose it
2 · Reply
NYNJlawyer
NYNJlawyer Dec. 22 at 6:05 PM
$FLNA down $1 in 3 minutes, as always
1 · Reply
vu_jade
vu_jade Dec. 22 at 6:04 PM
$FLNA Cassava my nuts
0 · Reply
Duboc1998
Duboc1998 Dec. 22 at 6:03 PM
$FLNA sammy2626 What did you do with your son that you adopted did he accept the $100 Zelle LOL
0 · Reply
Duboc1998
Duboc1998 Dec. 22 at 6:02 PM
$FLNA It’s only 10:01 AM California time guys another 3 hours of trading
0 · Reply
desik
desik Dec. 22 at 6:01 PM
$FLNA It's going back home to $35 and up. Just like I predicted!
1 · Reply
Duboc1998
Duboc1998 Dec. 22 at 6:00 PM
$FLNA REMOVED THOSE STOP LOSSES GUYS THE BIG BOYS ARE PICKING THEM UP
0 · Reply
Power2k
Power2k Dec. 22 at 5:59 PM
$FLNA Paper loss is never a loss, sell for a loss is a true loss! Hold your shares, our time is still comin!
0 · Reply
xPeViTe
xPeViTe Dec. 22 at 5:58 PM
$FLNA Really..someone managed to buy at 28? Well.. congrats, don't blow it now
0 · Reply
Power2k
Power2k Dec. 22 at 5:57 PM
$FLNA recovering, slowly but surely
0 · Reply
semifreeguy
semifreeguy Dec. 22 at 5:57 PM
$FLNA Never panic sell - a hard lesson inexperienced investors always have to learn
2 · Reply
QueenBeeBuzz
QueenBeeBuzz Dec. 22 at 5:56 PM
$FLNA I NEED TO GET TO BANK SO I CAN BUY MORE BEFORE GREAT TRIAL RESULTS COME OUT NEXT MONTH
0 · Reply
xPeViTe
xPeViTe Dec. 22 at 5:56 PM
$FLNA Storm is over, water is draining, sun will rise, heat will be as never felt before
1 · Reply
Duboc1998
Duboc1998 Dec. 22 at 5:53 PM
$FLNA Guys guys some of you remind me of some of my kids. Stop doubting yourselves.You made the decision to invest in this company and that’s that. If you’re doubting your decision then !!Get out!! There is no point in the stressing yourself. Life is too short
0 · Reply
JennySingh
JennySingh Dec. 22 at 5:52 PM
$FLNA Reentered because of the drop. Looking forward to next bounce. The price should go a lot higher than $45 as data update is coming soon...
0 · Reply
GaryJosephYellen
GaryJosephYellen Dec. 22 at 5:50 PM
$FLNA You think they decided to go after the fraud short team with a lawsuit with bad data…. They know the data is very good and sent it to a third party to make sure fudsters can rot in hell. Remember the inside buys and hiring of big time corporate attorney…. IMO I think not.
3 · Reply